Prof. Lv Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of the Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) of HKBU, and Chair Professor in Shanghai University of Traditional Chinese Medicine. He is the member of the 11th and 12th the National Committee of the Chinese People’s Consultative Conference (CPPCC). Prof. Lu is also the recipient of the Distinguished Young Scholar in National Science Foundation of China (NSFC) in 2007.
Beyond these achievements, he is also a Member of Medical Advisory Committee of National Natural Science Foundation of China (NSFC), Member of Chinese Pharmacopoeia Commission and Vice-Chairman, Terminology of Traditional Chinese Medicine Sub-Committee, China National Committee for Terms in Sciences and Technologies (CNCTST). He has also been appointed as Head & Spokesperson of the China Delegation, International Organization for Standardization of Technical Committee on TCM (ISO/TC249) since 2009.
His research interests mainly focus on the translational research of Chinese medicine, including pharmacological and clinical evaluation of rheumatoid arthritis with traditional Chinese medicine pattern diagnosis and interventions, and development of new drugs based on Chinese medicines. He is also actively involved in the research of the standardization of Chinese medicine and strategic planning and development of Chinese medicine in China.
Prof. Lv has published more than 30 books and over 500 articles, including 270 articles in SCI journals such as Nature Medicine, Nature Communication, Science Translational Medicine, Biomaterials, and Briefings in Bioinformatics. Over the years, he has obtained more than 60 patents from his research efforts. Prof. Lv has been awarded the Young and Middle-aged Experts with Outstanding Contributions (Ministry of Health of the People's Republic of China, 2003), and Award for Outstanding Contribution to Standardization in China (2014).